Prime Medicine Inc. (PRME)
NASDAQ: PRME
· Real-Time Price · USD
2.50
0.34 (15.74%)
At close: Jun 24, 2025, 3:59 PM
2.48
-0.66%
Pre-market: Jun 25, 2025, 06:15 AM EDT
15.74% (1D)
Bid | 2.48 |
Market Cap | 327.78M |
Revenue (ttm) | 41.62M |
Net Income (ttm) | -202.01M |
EPS (ttm) | -1.61 |
PE Ratio (ttm) | -1.55 |
Forward PE | -2.15 |
Analyst | Hold |
Ask | 2.53 |
Volume | 5,180,056 |
Avg. Volume (20D) | 2,165,437 |
Open | 2.28 |
Previous Close | 2.16 |
Day's Range | 2.15 - 2.52 |
52-Week Range | 1.11 - 6.75 |
Beta | 1.55 |
About PRME
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PRME
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PRME stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Prime Medicine Inc. is scheduled to release its earnings on Aug 4, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-11.94%
Prime Medicine shares are trading lower after HC W...
Unlock content with
Pro Subscription
7 months ago
-9.09%
Prime Medicine shares are trading lower after Chardan Capital cut its price target on the stock from $17 to $15.